2008/965/EC: Commission Decision of 5 December 2008 on financial aid from the Community for the year 2009 for certain Community reference laboratories in the field of animal health and live animals (notified under document number C(2008) 7667)
For African horse sickness, the Community grants financial assistance to the Laboratorio Central de Sanidad Animal de Algete, Algete (Madrid), Spain, to carry out the functions and duties set out in Annex III to Directive 92/35/EEC.
The Community’s financial assistance shall be at the rate of 100 % of the eligible costs as defined in Regulation (EC) No 1754/2006 to be incurred by that laboratory for the work programme and shall amount to a maximum of EUR 101 000 for the period from 1 January to 31 December 2009, of which a maximum of EUR 35 000 shall be dedicated to the organisation of a technical workshop on African horse sickness.
For Newcastle disease, the Community grants financial assistance to the Veterinary Laboratories Agency (VLA), New Haw, Weybridge, United Kingdom, to carry out the functions and duties set out in Annex V to Directive 92/66/EEC.
The Community’s financial assistance shall be at the rate of 100 % of the eligible costs as defined in Regulation (EC) No 1754/2006 to be incurred by that laboratory for the work programme and shall amount to a maximum of EUR 88 000 for the period from 1 January to 31 December 2009.
For swine vesicular disease, the Community grants financial assistance to the AFRC Institute for Animal Health, Pirbright Laboratory, Pirbright, United Kingdom, to carry out the functions and duties set out in Annex III to Directive 92/119/EEC.
The Community’s financial assistance shall be at the rate of 100 % of the eligible costs as defined in Regulation (EC) No 1754/2006 to be incurred by that laboratory for the work programme and shall amount to a maximum of EUR 125 000 for the period from 1 January to 31 December 2009.
For fish diseases, the Community grants financial assistance to the Technical University of Denmark, National Veterinary Institute, Department of Poultry, Fish and Fur Animals, Aarhus, Denmark, to carry out the functions and duties set out in Annex C to Directive 93/53/EEC.
The Community’s financial assistance shall be at the rate of 100 % of the eligible costs as defined in Regulation (EC) No 1754/2006 to be incurred by that laboratory for the work programme and shall amount to a maximum of EUR 255 000 for the period from 1 January to 31 December 2009.
For diseases of bivalve molluscs, the Community grants financial assistance to the IFREMER, La Tremblade, France, to carry out the functions and duties set out in Annex B to Directive 95/70/EC.
The Community’s financial assistance shall be at the rate of 100 % of the eligible costs as defined in Regulation (EC) No 1754/2006 to be incurred by that institute for the work programme and shall amount to a maximum of EUR 105 000 for the period from 1 January to 31 December 2009.
For rabies serology, the Community grants financial assistance to the AFSSA, Laboratoire d’études sur la rage et la pathologie des animaux sauvages, Nancy, France, to carry out the functions and duties set out in Annex II to Decision 2000/258/EC.
The Community’s financial assistance shall be at the rate of 100 % of the eligible costs as defined in Regulation (EC) No 1754/2006 to be incurred by that laboratory for the work programme and shall amount to a maximum of EUR 205 000 for the period from 1 January to 31 December 2009.
For bluetongue, the Community grants financial assistance to the AFRC Institute for Animal Health, Pirbright Laboratory, Pirbright, United Kingdom, to carry out the functions and duties set out in Annex II(B) to Directive 2000/75/EC.
The Community’s financial assistance shall be at the rate of 100 % of the eligible costs as defined in Regulation (EC) No 1754/2006 to be incurred by that laboratory for the work programme and shall amount to a maximum of EUR 298 000 for the period from 1 January to 31 December 2009.
For classical swine fever, the Community grants financial assistance to the Institut für Virologie der Tierärztlichen Hochschule Hannover, Hannover, Germany, to carry out the functions and duties set out in Annex IV to Directive 2001/89/EC.
The Community’s financial assistance shall be at the rate of 100 % of the eligible costs as defined in Regulation (EC) No 1754/2006 to be incurred by that institute for the work programme and shall amount to a maximum of EUR 215 000 for the period from 1 January to 31 December 2009.
For African swine fever, the Community grants financial assistance to the Centro de Investigación en Sanidad Animal, Valdeolmos, Madrid, Spain, to carry out the functions and duties set out in Annex V to Directive 2002/60/EC.
The Community’s financial assistance shall be at the rate of 100 % of the eligible costs as defined in Regulation (EC) No 1754/2006 to be incurred by that research centre for the work programme and shall amount to a maximum of EUR 208 000 for the period from 1 January to 31 December 2009 of which a maximum of EUR 43 000 shall be dedicated to the organisation of a technical workshop on African swine fever.
By way of derogation from Article 13(1) of Regulation (EC) No 1754/2006, the laboratory referred to in the first paragraph shall be entitled to claim financial assistance for attendance by a maximum of 50 participants at one of its workshops referred to in the second paragraph of this Article.
For foot-and-mouth disease, the Community grants financial assistance to the Institute for Animal Health, Pirbright Laboratory, of the Biotechnology and Biological Sciences Research Council (BBSRC), Pirbright, United Kingdom, to carry out the functions and duties set out in Annex XVI to Directive 2003/85/EC.
The Community’s financial assistance shall be at the rate of 100 % of the eligible costs as defined in Regulation (EC) No 1754/2006 to be incurred by that laboratory for the work programme and shall amount to a maximum of EUR 300 000 for the period from 1 January to 31 December 2009.
For collaborating in rendering uniform the testing methods and the assessment of the results for pure-bred breeding animals of the bovine species, the Community grants financial assistance to the INTERBULL Centre, Department of Animal Breeding and Genetics, Swedish University of Agricultural Sciences, Uppsala, Sweden, to carry out the functions and duties set out in Annex II to Decision 96/463/EC.
The Community’s financial assistance shall be at the rate of 100 % of the eligible costs as defined in Regulation (EC) No 1754/2006 to be incurred by that centre for the work programme and shall amount to a maximum of EUR 91 000 for the period from 1 January to 31 December 2009.
For brucellosis, the Community grants financial assistance to the AFSSA, Laboratoire d’études et de recherches en pathologie animale et zoonoses, Maisons-Alfort, France, to carry out the functions and duties set out in Article 32(2) of Regulation (EC) No 882/2004.
The Community’s financial assistance shall be at the rate of 100 % of the eligible costs as defined in Regulation (EC) No 1754/2006 to be incurred by that laboratory for the work programme and shall amount to a maximum of EUR 269 000 for the period from 1 January to 31 December 2009, of which a maximum of EUR 28 000 shall be dedicated to the organisation of a technical workshop on brucellosis diagnostic techniques.
For avian influenza, the Community grants financial assistance to the Veterinary Laboratories Agency (VLA), New Haw, Weybridge, United Kingdom, to carry out the functions and duties set out in Annex VII to Directive 2005/94/EC.
The Community’s financial assistance shall be at the rate of 100 % of the eligible costs as defined in Regulation (EC) No 1754/2006 to be incurred by that laboratory for the work programme and shall amount to a maximum of EUR 400 000 for the period from 1 January to 31 December 2009.
For crustacean diseases, the Community grants financial assistance to the Centre for Environment, Fisheries & Aquaculture Science (Cefas), Weymouth Laboratory, United Kingdom, to carry out the functions and duties set out in Part I Annex VI to Directive 2006/88/EC.
The Community’s financial assistance shall be at the rate of 100 % of the eligible costs as defined in Regulation (EC) No 1754/2006 to be incurred by that laboratory for the work programme and shall amount to a maximum of EUR 95 000 for the period from 1 January to 31 December 2009.
For equine diseases other than African Horse Sickness, the Community grants financial assistance to the AFSSA, Laboratoire d’études et de recherches en pathologie animale et zoonoses/Laboratoire d’études et de recherche en pathologie equine, France, to carry out the functions and duties set out in the Annex to Regulation (EC) No 180/2008.
The Community’s financial assistance shall be at the rate of 100 % of the eligible costs as defined in Regulation (EC) No 1754/2006 to be incurred by that laboratory for the work programme and shall amount to a maximum of EUR 515 000 for the period from 1 January to 31 December 2009 of which a maximum of EUR 40 000 shall be dedicated to the organisation of a technical workshop on equine diseases.
For rabies, the Community grants financial assistance to the AFSSA, Laboratoire d’études sur la rage et la pathologie des animaux sauvages, Nancy, France, to carry out the functions and duties set out in Annex I to Regulation (EC) No 737/2008.
The Community’s financial assistance shall be at the rate of 100 % of the eligible costs as defined in Regulation (EC) No 1754/2006 to be incurred by that laboratory for the work programme and shall amount to a maximum of EUR 285 000 for the period from 1 January to 31 December 2009, of which a maximum of EUR 25 000 shall be dedicated to the organisation of a technical workshop on rabies.
For tuberculosis, the Community grants financial assistance to the Laboratorio de Vigilancia Veterinaria (VISAVET) of the Facultad de Veterinaria, Universidad Complutense de Madrid, Madrid, Spain, to carry out the functions and duties set out in Annex II to Regulation (EC) No 737/2008.
The Community’s financial assistance shall be at the rate of 100 % of the eligible costs as defined in Regulation (EC) No 1754/2006 to be incurred by that laboratory for the work programme and shall amount to a maximum of EUR 205 000 for the period from 1 January to 31 December 2009, of which a maximum of EUR 25 000 shall be dedicated to the organisation of a technical workshop on tuberculosis.
This Decision is addressed to:
—
for African horse sickness: Laboratorio Central de Sanidad Animal, Ministerio de Medio Ambiente y Medio Rural Y Marinos, Ctra. De Algete km 8, Valdeolmos, E-28110, Algete, Madrid; Sra Concepción Gómez Tejedor, Tel. (34) 916 29 03 00,
—
for Newcastle disease: Veterinary Laboratories Agency (VLA), Weybridge, New Haw, Addlestone, Surrey KT15 3NB, United Kingdom; Mr Ian Brown, Tel. (44) 1932 35 73 39,
—
for swine vesicular disease: AFRC Institute for Animal Health, Pirbright Laboratory, Pirbright, Woking, Surrey GU24 ONF, United Kingdom; Mr D. J. Paton, Tel. (44) 7900 16 20 31,
—
for fish diseases: Danmarks Tekniske Universitet, Veterinæinstituttet, Afdeling for Fjerkræ, Fiske og Pelsdyr, Hangøvej 2, DK-8200 Århus, Danmark; Kristian Møller, Tel. (45) 72 34 61 89,
—
for diseases of bivalve molluscs: Ifremer, B.P. 133 F-17390, La Tremblade; Mme Isabelle Arzul, Tel. (33) 546 76 26 47,
—
for rabies serology: AFSSA, Laboratoire d’études sur la rage et la pathologie des animaux sauvages de l'AFSSA, site de Nancy, Domaine de Pixérécourt, BP 9, F-54220 Malzéville; Mme Florence Cliquet, Tel. (33) 383 29 89 50,
—
for bluetongue: AFRC Institute for Animal Health, Pirbright Laboratory, Pirbright, Woking, Surrey GU24 ONF, United Kingdom; Mr D.J. Paton, Tel. (44) 7900 16 20 31,
—
for classical swine fever: Institut für Virologie der Tierärztlichen Hochschule Hannover, Bischofsholer Damm 15, D-30173 Hannover; Herr Peter Joppe, Tel. (49-511) 953 80 20,
—
for African swine fever: Centro de Investigación en Sanidad Animal, Valdeolmos, Ctra. De Algete a El Casar, E-28130 Valdeolmos, Madrid; Sra Marisa Arias, Tel. (34) 600 31 51 89,
—
for foot-and-mouth disease: AFRC Institute for Animal Health, Pirbright Laboratory, Pirbright, Woking, Surrey GU24 ONF, United Kingdom; Mr D.J. Paton, Tel. (44) 7900 16 20 31,
—
for collaborating in rendering uniform the testing methods and the assessment of the results for pure-bred breeding animals of the bovine species: Interbull Centre, Institionen för husdjusgenetik, Sveriges lantbruksuniversitet, Box: 7023; S-75007 Uppsala, Sweden; Mr João Walter Dürr, Tel. (46-18) 67 20 98,
—
for brucellosis: Laboratoire d’études et de recherches en pathologie animale et zoonoses de l'AFFSSA, 23, avenue du Général de Gaulle, F-94706 Maisons-Alfort, Cedex; Mr Bruno Garin-Bastuji, Tel. (33) 607 94 26 31,
—
for avian influenza: Veterinary Laboratories Agency (VLA) Weybridge, New Haw, Addlestone, Surrey KT15 3NB, United Kingdom; Mr Ian Brown, Tel. (44) 1932 35 73 39,
—
for crustacean diseases: Centre for Environment, Fisheries & Aquaculture Science (Cefas), Weymouth Laboratory, The Nothe, Barrack Road, Weymouth, Dorset DT4 8UB, United Kingdom; Mr David Grant Stentiford, Tel. (44) 1305 20 67 22,
—
for equine diseases: Laboratoire d’études et de recherches en pathologie animale et zoonoses de l'AFSSA, 23 avenue du Général de Gaulle, F-94706 Maisons-Alfort, Cedex; Mr Stéphan Zientara, Tel. (33) 143 96 72 80,
—
for rabies: Laboratoire d’études sur la rage et la pathologie des animaux sauvages de l'AFSSA, site de Nancy, Domaine de Pixérécourt, BP 9, F-54220 Malzéville, France; Mme Florence Cliquet, Tel. (33) 383 29 89 50,
—
for tuberculosis: Visavet, Laboratorio de Vigilancia Veterinaria, Facultad de Veterinaria de la Universidad Complutense de Madrid, Avda. Puerta de Hierro, s/n. Ciudad Universitaria, E-28040, Madrid; Sra. Alicia Aranaz, Tel. (34) 913 94 39 92.
Source: EUR-Lex (Publications Office of the EU), © European Union, reuse permitted under Commission Decision 2011/833/EU.
